Yubo International Biotech Ltd Quarterly Amortization of Intangible Assets in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Yubo International Biotech Ltd quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2020 to Q3 2024.
  • Yubo International Biotech Ltd Amortization of Intangible Assets for the quarter ending September 30, 2024 was $3.59K, a 25.4% increase year-over-year.
  • Yubo International Biotech Ltd Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $13.3K, a 12.3% increase year-over-year.
  • Yubo International Biotech Ltd annual Amortization of Intangible Assets for 2023 was $11.7K, a 24% increase from 2022.
  • Yubo International Biotech Ltd annual Amortization of Intangible Assets for 2022 was $9.44K, a 15.4% increase from 2021.
  • Yubo International Biotech Ltd annual Amortization of Intangible Assets for 2021 was $8.18K, a 99.7% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.3K $3.59K +$728 +25.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $12.6K $3.4K +$590 +21% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $12K $3.23K +$266 +8.96% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $11.7K $3.06K -$126 -3.96% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-12
Q3 2023 $11.8K $2.86K +$654 +29.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $11.2K $2.81K +$816 +40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $10.4K $2.97K +$917 +44.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 $9.44K $3.19K +$994 +45.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 $8.45K $2.21K +$564 +34.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $7.88K $1.99K -$196 -8.95% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $8.08K $2.05K -$103 -4.78% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $8.18K $2.19K +$25.00 +1.15% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 $8.16K $1.64K -$285 -14.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-16
Q2 2021 $8.44K $2.19K +$2.19K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $6.25K $2.15K +$2.15K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.1K $2.17K Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 $1.93K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-20
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.